|
JP3917662B2
(ja)
|
1996-02-14 |
2007-05-23 |
日立化成工業株式会社 |
非複屈折性光学用樹脂組成物及びこれを用いた光学用素子
|
|
PL332187A1
(en)
|
1996-09-04 |
1999-08-30 |
Pfizer |
Substitution derivatives of indazole and their application as inhibitors of phosphodiesterase (pde) of iv type and tumor necrosis factor (tnf)
|
|
US6258822B1
(en)
*
|
1997-08-06 |
2001-07-10 |
Abbott Laboratories |
Urokinase inhibitors
|
|
US6133290A
(en)
|
1998-07-31 |
2000-10-17 |
Eli Lilly And Company |
5-HT1F agonists
|
|
US20020147198A1
(en)
|
2001-01-12 |
2002-10-10 |
Guoqing Chen |
Substituted arylamine derivatives and methods of use
|
|
US20030134836A1
(en)
|
2001-01-12 |
2003-07-17 |
Amgen Inc. |
Substituted arylamine derivatives and methods of use
|
|
US7102009B2
(en)
|
2001-01-12 |
2006-09-05 |
Amgen Inc. |
Substituted amine derivatives and methods of use
|
|
US7105682B2
(en)
|
2001-01-12 |
2006-09-12 |
Amgen Inc. |
Substituted amine derivatives and methods of use
|
|
US6995162B2
(en)
|
2001-01-12 |
2006-02-07 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
|
KR20050004214A
(ko)
|
2002-05-31 |
2005-01-12 |
에자이 가부시키가이샤 |
피라졸 화합물 및 이것을 포함하여 이루어지는 의약 조성물
|
|
CN1839126A
(zh)
|
2003-02-28 |
2006-09-27 |
拜耳制药公司 |
用于治疗癌症和其它病症的新的氰基吡啶衍生物
|
|
WO2004078723A1
(ja)
|
2003-03-07 |
2004-09-16 |
Santen Pharmaceutical Co. Ltd. |
４－ピリジルアルキルチオ基を置換基として有する新規化合物
|
|
ES2350837T3
(es)
|
2003-05-01 |
2011-01-27 |
Bristol-Myers Squibb Company |
Compuestos de pirazol-amida sustituidos con arilo útiles como inhibidores de quinasas.
|
|
EP1628661A2
(en)
|
2003-06-05 |
2006-03-01 |
Vertex Pharmaceuticals Incorporated |
Modulators of vr1 receptor
|
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
WO2005074642A2
(en)
|
2004-01-30 |
2005-08-18 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
DE102004028862A1
(de)
|
2004-06-15 |
2005-12-29 |
Merck Patent Gmbh |
3-Aminoindazole
|
|
WO2006032851A1
(en)
|
2004-09-20 |
2006-03-30 |
Biolipox Ab |
Pyrazole compounds useful in the treatment of inflammation
|
|
DE102004051277A1
(de)
|
2004-10-21 |
2006-04-27 |
Merck Patent Gmbh |
Heterocyclische Carbonylverbindungen
|
|
WO2006053109A1
(en)
|
2004-11-10 |
2006-05-18 |
Synta Pharmaceuticals Corp. |
Heteroaryl compounds
|
|
TW200628159A
(en)
|
2004-11-10 |
2006-08-16 |
Synta Pharmaceuticals Corp |
IL-12 modulatory compounds
|
|
CN101146796A
(zh)
|
2005-01-26 |
2008-03-19 |
先灵公司 |
作为蛋白激酶抑制剂用于治疗癌症的3-(吲唑-5-基)-(1,2,4)三嗪衍生物及相关化合物
|
|
MX2007011234A
(es)
|
2005-03-14 |
2007-11-12 |
Transtech Pharma Inc |
Derivados de benzazol, composiciones y metodos de uso en la forma de inhibidores de b-secretasa.
|
|
DE102005014089A1
(de)
|
2005-03-22 |
2006-09-28 |
Schering Ag |
Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
|
|
WO2006132914A2
(en)
|
2005-06-03 |
2006-12-14 |
Abbott Laboratories |
Cyclobutyl amine derivatives
|
|
FR2889526B1
(fr)
|
2005-08-04 |
2012-02-17 |
Aventis Pharma Sa |
7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
|
US8247556B2
(en)
|
2005-10-21 |
2012-08-21 |
Amgen Inc. |
Method for preparing 6-substituted-7-aza-indoles
|
|
WO2007058626A1
(en)
|
2005-11-16 |
2007-05-24 |
S*Bio Pte Ltd |
Indazole compounds
|
|
CA2640091A1
(en)
|
2006-01-25 |
2007-08-02 |
Synta Pharmaceuticals Corp. |
Vinyl-phenyl derivatives for inflammation and immune-related uses
|
|
AU2007215247B2
(en)
|
2006-02-10 |
2012-12-13 |
Transtech Pharma, Llc |
Benzazole derivatives, compositions, and methods of use as Aurora kinase inhibitors
|
|
US8658801B2
(en)
|
2006-02-16 |
2014-02-25 |
Syngenta Crop Protection, Llc |
Pesticides containing a bicyclic bisamide structure
|
|
AU2007227210A1
(en)
|
2006-03-20 |
2007-09-27 |
Synta Pharmaceuticals Corp. |
Benzoimidazolyl-parazine compounds for inflammation and immune-related uses
|
|
CA2646886A1
(en)
|
2006-03-23 |
2007-10-04 |
Synta Pharmaceuticals Corp. |
Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
|
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
|
PE20080888A1
(es)
|
2006-10-18 |
2008-08-26 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE LA ACIL-TRANSFERASA DE ACIL-CoA-DIACIL-GLICEROL 1 (DGAT1)
|
|
US7960567B2
(en)
|
2007-05-02 |
2011-06-14 |
Amgen Inc. |
Compounds and methods useful for treating asthma and allergic inflammation
|
|
GB0716414D0
(en)
|
2007-08-22 |
2007-10-03 |
Syngenta Participations Ag |
Novel insecticides
|
|
WO2009035951A2
(en)
|
2007-09-11 |
2009-03-19 |
Arete Therapeutics, Inc. |
Soluble epoxide hydrolase inhibitors
|
|
US8324219B2
(en)
|
2007-09-20 |
2012-12-04 |
Synta Pharmaceuticals Corp. |
Substituted benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
|
|
WO2009038784A1
(en)
|
2007-09-21 |
2009-03-26 |
Amgen Inc. |
Triazole fused heteroaryl compounds as p38 kinase inhibitors
|
|
DE102007047735A1
(de)
|
2007-10-05 |
2009-04-09 |
Merck Patent Gmbh |
Thiazolderivate
|
|
US8362056B2
(en)
|
2007-11-05 |
2013-01-29 |
Array Biopharma Inc. |
4-heteroaryl-substituted phenoxyphenylacetic acid derivatives
|
|
AU2008323628B2
(en)
|
2007-11-15 |
2013-10-17 |
Ym Biosciences Australia Pty Ltd |
N-containing heterocyclic compounds
|
|
WO2009073788A1
(en)
|
2007-12-07 |
2009-06-11 |
Firestone Leigh H |
Compositions and methods for treating menopausal females
|
|
WO2009112445A1
(en)
|
2008-03-10 |
2009-09-17 |
Novartis Ag |
Method of increasing cellular phosphatidyl choline by dgat1 inhibition
|
|
CA2722704A1
(en)
|
2008-04-28 |
2009-11-05 |
Zalicus Pharmaceuticals Ltd. |
Cyclylamine derivatives as calcium channel blockers
|
|
NZ603525A
(en)
|
2008-06-27 |
2015-02-27 |
Celgene Avilomics Res Inc |
Pyrimidine based compound and uses thereof
|
|
JO3041B1
(ar)
|
2008-07-25 |
2016-09-05 |
Galapagos Nv |
مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية
|
|
WO2010029300A1
(en)
|
2008-09-12 |
2010-03-18 |
Biolipox Ab |
Bis aromatic compounds for use in the treatment of inflammation
|
|
CA2757415C
(en)
|
2009-04-02 |
2018-02-06 |
Merck Patent Gmbh |
Autotaxin inhibitors
|
|
MX2012003394A
(es)
|
2009-09-21 |
2012-08-15 |
Univ Vanderbilt |
Analogos de la nicotinamida de o-bencilo como moduladores alostéricos positivos del mglur5.
|
|
US20120202814A1
(en)
|
2009-10-02 |
2012-08-09 |
Università Degli Studi Di Siena |
Compounds with ddx3 inhibitory activity and uses thereof
|
|
WO2011123937A1
(en)
|
2010-04-06 |
2011-10-13 |
University Health Network |
Kinase inhibitors and method of treating cancer with same
|
|
JP2013525370A
(ja)
|
2010-04-22 |
2013-06-20 |
ヤンセン ファーマシューティカ エヌ．ベー． |
ケトヘキソキナーゼ阻害剤として有用なインダゾール化合物
|
|
AR081626A1
(es)
|
2010-04-23 |
2012-10-10 |
Cytokinetics Inc |
Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
|
|
EP2560488B1
(en)
|
2010-04-23 |
2015-10-28 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
|
HUE029570T2
(en)
|
2010-04-27 |
2017-03-28 |
Calcimedica Inc |
Intracellular calcium modifying compounds
|
|
EP2563358A4
(en)
|
2010-04-30 |
2013-09-25 |
Merck Sharp & Dohme |
INHIBITORS OF PHOSPHOINOSITIDE-DEPENDENT KINASE 1 (PDK1)
|
|
WO2012025638A1
(en)
|
2010-08-27 |
2012-03-01 |
Universität des Saarlandes |
Selective 17beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
|
SI2616444T1
(sl)
|
2010-09-14 |
2016-03-31 |
Instytut Biochemii I Biofizyki Pan |
Spojine kot modulatorji mutantnega cftr proteina in njihova uporaba za zdravljenje bolezni, povezanih s cftr proteinsko okvaro
|
|
SI2638031T1
(en)
*
|
2010-11-10 |
2018-02-28 |
Genentech, Inc. |
Pyrazole aminopyrimidine derivatives as LRRK2 modulators
|
|
US8791112B2
(en)
|
2011-03-30 |
2014-07-29 |
Arrien Pharmaceuticals Llc |
Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-B] pyridine and pyrazolo [3, 4-B] pyridine derivatives as protein kinase inhibitors
|
|
US8569511B2
(en)
|
2011-04-01 |
2013-10-29 |
University Of Utah Research Foundation |
Substituted 3-(1H-benzo[d]imidazol-2-yl)-1H-indazole analogs as inhibitors of the PDK1 kinase
|
|
AU2012258977A1
(en)
|
2011-05-23 |
2014-01-16 |
Imago Pharmaceuticals, Inc. |
Inhibitors of LRRK2 kinase activity
|
|
CA2849194A1
(en)
|
2011-11-01 |
2013-05-10 |
F. Hoffmann-La Roche Ag |
Imidazopyridazine compounds
|
|
WO2013102145A1
(en)
|
2011-12-28 |
2013-07-04 |
Global Blood Therapeutics, Inc. |
Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
AU2013208104B2
(en)
|
2012-01-09 |
2017-11-23 |
X-Chem, Inc. |
Benzhydrol-pyrazole derivatives having kinase inhibitory activity and uses thereof
|
|
BR112014024552A2
(pt)
|
2012-04-02 |
2017-09-19 |
Cytokinetics Inc |
método para aprimorar a função do diafragma em um paciente que necessite do mesmo; método para aumentar a função, atividade, eficiência, sensibilidade ao cálcio ou tempo de fadiga do músculo esquelético no diafragma de um paciente que necessite do mesmo e método para aumentar a função, atividade, eficiência, força, sensibilidade ao cálcio ou tempo de fadiga de uma fibra muscular esquelética do diafragma.
|
|
US8962322B2
(en)
|
2012-12-03 |
2015-02-24 |
City Of Hope |
Enhancers of induced pluripotent stem cell reprogramming
|
|
ME03780B
(me)
|
2013-01-15 |
2021-04-20 |
Incyte Holdings Corp |
Jedinjenja tiazolkarboksamida i piridinkarboksamida korisna kao inhibitori pim kinaze
|
|
WO2014134774A1
(en)
|
2013-03-04 |
2014-09-12 |
Merck Sharp & Dohme Corp. |
Compounds inhibiting leucine-rich repeat kinase enzyme activity
|
|
US20160024071A1
(en)
|
2013-03-15 |
2016-01-28 |
Elan Pharmaceuticals, Llc |
Inhibitors of lrrk2 kinase activity
|
|
US10005720B2
(en)
|
2013-04-05 |
2018-06-26 |
North Carolina Central University |
Compounds useful for the treatment of metabolic disorders and synthesis of the same
|
|
AU2014274093B2
(en)
|
2013-05-30 |
2018-11-08 |
Plexxikon Inc. |
Compounds for kinase modulation, and indications therefor
|
|
US9359354B2
(en)
|
2013-06-06 |
2016-06-07 |
Chiesi Farmaceutici S.P.A. |
Kinase inhibitors
|
|
CA2911963A1
(en)
|
2013-06-21 |
2014-12-24 |
F. Hoffmann-La Roche Ag |
Aryl sultam derivatives as rorc modulators
|
|
GEP20186876B
(en)
|
2013-08-02 |
2018-07-10 |
Pfizer |
Heterobicycloaryl rorc2 inhibitors and methods of use thereof
|
|
US9718818B2
(en)
|
2013-08-22 |
2017-08-01 |
Merck Sharp & Dohme Corp. |
Compounds inhibiting leucine-rich repeat kinase enzyme activity
|
|
AU2014369053B2
(en)
|
2013-12-20 |
2019-03-14 |
Institute For Drug Discovery, Llc |
Substituted amino triazoles, and methods using same
|
|
WO2016036586A1
(en)
|
2014-09-03 |
2016-03-10 |
Merck Sharp & Dohme Corp. |
Compounds inhibiting leucine-rich repeat kinase enzyme activity
|
|
US20160113931A1
(en)
|
2014-10-24 |
2016-04-28 |
University Of Macau |
Method of treating and/or preventing neurodegenerative diseases
|
|
JP2018500388A
(ja)
|
2014-11-18 |
2018-01-11 |
ラットガーズ、ザ ステート ユニバーシティ オブ ニュージャージー |
代謝疾患及び癌の治療のための、新規ミトコンドリアアンカップラー
|
|
JO3705B1
(ar)
|
2014-11-26 |
2021-01-31 |
Bayer Pharma AG |
إندازولات مستبدلة جديدة، عمليات لتحضيرها، مستحضرات دوائية تحتوي عليها واستخدامها في إنتاج أدوية
|
|
EP3270694A4
(en)
|
2015-02-17 |
2018-09-05 |
Neupharma, Inc. |
Certain chemical entities, compositions, and methods
|
|
WO2016144702A1
(en)
|
2015-03-06 |
2016-09-15 |
Pharmakea, Inc. |
Lysyl oxidase-like 2 inhibitors and uses thereof
|
|
KR20180030201A
(ko)
*
|
2015-07-23 |
2018-03-21 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
화합물
|
|
AU2016306301B2
(en)
|
2015-08-07 |
2021-02-11 |
Calcimedica, Inc. |
Use of CRAC channel inhibitors for the treatment of stroke and traumatic brain injury
|
|
WO2017049172A1
(en)
|
2015-09-16 |
2017-03-23 |
Metacrine, Inc. |
Farnesoid x receptor agonists and uses thereof
|
|
WO2017049409A1
(en)
|
2015-09-25 |
2017-03-30 |
The Centre For Drug Research And Development |
Compositions for promoting readthrough of premature termination codons, and methods of using the same
|
|
JP2019513700A
(ja)
|
2016-03-16 |
2019-05-30 |
バイエル・クロップサイエンス・アクチェンゲゼルシャフト |
殺有害生物剤及び植物保護剤としてのｎ−（シアノベンジル）−６−（シクロプロピル−カルボニルアミノ）−４−（フェニル）−ピリジン−２−カルボキサミド誘導体及び関連する化合物
|
|
WO2017163078A1
(en)
|
2016-03-24 |
2017-09-28 |
Mission Therapeutics Limited |
1-cyano-pyrrolidine derivatives as dbu inhibitors
|
|
US10933068B2
(en)
*
|
2016-05-26 |
2021-03-02 |
Sonic Master Limited |
Modulators of DUX4 for regulation of muscle function
|
|
TWI800498B
(zh)
|
2016-12-21 |
2023-05-01 |
義大利商吉斯藥品公司 |
作為Rho-激酶抑制劑之雙環二氫嘧啶-羧醯胺衍生物
|
|
US20210130339A1
(en)
|
2017-01-25 |
2021-05-06 |
Glaxosmithkline Intellectual Property Development Limited |
Compounds
|
|
EP3573975A4
(en)
|
2017-01-25 |
2020-08-12 |
GlaxoSmithKline Intellectual Property Management Limited |
LINKS
|
|
BR112019015252A2
(pt)
|
2017-01-25 |
2020-04-14 |
Glaxosmithkline Ip Dev Ltd |
compostos
|
|
WO2018140513A1
(en)
|
2017-01-26 |
2018-08-02 |
Araxes Pharma Llc |
1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer
|
|
EP3621962A4
(en)
|
2017-05-10 |
2020-12-09 |
Forge Therapeutics, Inc. |
ANTIBACTERIAL COMPOUNDS
|
|
CN107176932B
(zh)
|
2017-05-26 |
2020-06-05 |
中国药科大学 |
苯并恶嗪酮衍生物及其制备方法和用途
|
|
WO2019002624A1
(de)
|
2017-06-30 |
2019-01-03 |
Kleuser, Burkhard |
Mittel zur therapie entzündlicher darmerkrankungen
|
|
PE20200756A1
(es)
|
2017-08-16 |
2020-07-27 |
Univ Vanderbilt |
Compuestos de indazol como potenciadores alostericos mglur4, composiciones y metodos de tratamiento de la disfuncion neurologica
|
|
US11174248B2
(en)
|
2017-10-11 |
2021-11-16 |
Merck Sharp & Dohme Corp. |
Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
|
|
US11161854B2
(en)
|
2017-10-11 |
2021-11-02 |
Merck Sharp & Dohme Corp. |
Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
|
|
US11696928B2
(en)
|
2017-11-03 |
2023-07-11 |
Universite De Montreal |
Compounds and use thereof in the expansion of stem cells and/or progenitor cells
|
|
US20210261553A1
(en)
|
2018-05-15 |
2021-08-26 |
E-Scape Bio, Inc. |
Fused tetrazoles as lrrk2 inhibitors
|
|
WO2020092136A1
(en)
|
2018-10-31 |
2020-05-07 |
Merck Sharp & Dohme Corp. |
N-heteroaryl indazole derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof
|
|
US20220204473A1
(en)
|
2018-12-25 |
2022-06-30 |
Shanghai Meiyue Biotech Development Co., Ltd. |
Compound as irak inhibitor
|
|
WO2020191261A1
(en)
|
2019-03-21 |
2020-09-24 |
E-Scape Bio, Inc. |
Indazoles as lrrk2 inhibitors
|
|
WO2020228649A1
(zh)
|
2019-05-10 |
2020-11-19 |
上海海雁医药科技有限公司 |
取代的苯基丙烯基吡啶类衍生物，其制法与医药上的用途
|
|
WO2020247298A2
(en)
|
2019-06-06 |
2020-12-10 |
Merck Sharp & Dohme Corp. |
1-pyrazolyl, 5-, 6- disubstituted indazole derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof
|
|
WO2021050688A1
(en)
|
2019-09-10 |
2021-03-18 |
X-Chem, Inc. |
Compounds and uses thereof
|
|
EP4056558A4
(en)
|
2019-11-06 |
2023-12-27 |
Jinan University |
INDAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USES THEREOF
|
|
WO2021222789A1
(en)
|
2020-05-01 |
2021-11-04 |
The Regents Of The University Of California |
Inhibitors of alpha 2 beta 1 integrin and methods of use thereof
|